ACTITREXX GMBH
ActiTrexx GmbH prevent the development of GvHD at an early stage with the cellular therapy ATreg and thus to provide a curative therapy
ACTITREXX GMBH
Founded:
2019-01-01
Address:
Mainz, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.actitrexx.de
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apache Euro IPv6 Microsoft Azure DNS DigiCert SSL Encryption Everywhere
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - ActiTrexx GmbH
MediVentures
MediVentures investment in Series A - ActiTrexx GmbH
LBBW VC
LBBW VC investment in Series A - ActiTrexx GmbH
Investitions- und Strukturbank Rheinland-Pfalz
Investitions- und Strukturbank Rheinland-Pfalz investment in Series A - ActiTrexx GmbH
Official Site Inspections
http://www.actitrexx.de
- Host name: 217-160-0-137.elastic-ssl.ui-r.com
- IP address: 217.160.0.137
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
